This study was conducted to determine the effects of a tablet combining losartan/hydrochlorothiazide (L/HCTZ) in comparison with losartan alone in Japanese diabetic patients with hypertension. Thirty ...

The Kobe combination therapy of losartan plus HCTZ (losartan/HCTZ), effect and safety trial (Kobe-CONNECT) Study was designed to compare the effectiveness and safety of losartan/HCTZ with that of the ...

Whitehouse Station, NJ - Merck & Co announced Friday that the FDA approved its product Hyzaar ®, a fixed-dose combination of the angiotensin receptor blocker losartan and the diuretic ...

Patients with severe hypertension are at high risk for cardiovascular events. The authors hypothesized that initial treatment with a combination angiotensin receptor blocker/diuretic agent would be ...

Granules India Limited announced today that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA) for Losartan Potassium and Hydrochlorothiazide Tablets ...

Participants assigned losartan/hydrochlorothiazide had a 1-mmol/L increase in two-hour OGTT glucose values at week 12 and a 1.6-mmol/L increase for week 52 (P <.001 for both) compared with ...

Multiple lots of drugs containing the active ingredient Losartan are being voluntarily recalled by the manufacturers, according to Health Canada, because they might contain a potential human ...

The US Food and Drug Administration says another heart medicine is being voluntarily recalled after tests showed that it was tainted with a potential cancer-causing chemical. The new recall of ...

PRINCETON, N.J., Nov. 8, 2018 /PRNewswire/ -- Sandoz Inc. is voluntarily recalling one lot of Losartan Potassium Hydrochlorothiazide Tablets, USP 100mg/25mg to the consumer level. This product is ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Torrent Pharmaceuticals is the most ...